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Abstract  
Oligomerisation of membrane proteins in response to lipid binding plays a critical role in many 
cell-signaling pathways [1] but is often difficult to define [2] or predict [3]. Here we develop a 
mass spectrometry platform to determine simultaneously the presence of interfacial lipids and 
oligomeric stability and discover how lipids act as key regulators of membrane protein association. 
We reasoned that stability would relate to free energy of oligomeric dissociation (ΔG°dissoc(m)), 
buried surface area and number of salt bridge interactions.  Calculating these values for a dataset 
of 125 α-helical oligomeric membrane proteins revealed an absence of interfacial lipids in the 
mass spectra of 13 membrane proteins with high oligomeric stability. For the protein with the 
lowest oligomeric stability, the bacterial homologue of the eukaryotic bioamine transporters 
(LeuT) [4, 5], we found a precise cohort of lipids within the dimer interface. Delipidation, mutation 
of lipid binding sites or expression in cardiolipin (CDL) deficient Escherichia coli, abrogated dimer 
formation. Molecular dynamics simulation revealed that CDL acts as a bidentate ligand bridging 
across subunits. Subsequently, we show that for the sugar transporter SemiSWEET from Vibrio 
splendidus [6], another protein with low oligomeric stability, cardiolipin shifts the equilibrium 
from monomer to functional dimer. We hypothesised that lipids would be essential for 
dimerisation of the Na+/H+ antiporter NhaA from E. coli, but not for homologous NapA from T. 
thermophilus, which has a ΔG°dissoc(m) considerably higher than that of NhaA.  We found that lipid 
binding is obligatory for dimerisation of NhaA, whereas NapA has adapted to form an interface 
that is stable without lipids. Overall, by correlating free energy of dissociation with presence of 
interfacial lipids we provide a rationale for understanding the role of lipids in both transient and 
stable interactions within a range of α-helical membrane proteins, including GPCRs. 
The recent surge in structure determination of membrane proteins is providing details of protein-
lipid binding [7] and yielding insight into the regulatory roles of lipids [8, 9]. The advent of mass 
spectrometry (MS) methods for characterising membrane proteins, individually [10], within 
interactomes [11], and in intact assemblies [12], is adding new information to potential roles of 
lipids inducing conformational changes [13], contributing to activity and modulating drug efflux, 
(reviewed in [14]). The role of lipids towards maintaining the oligomeric state of membrane proteins 
has however remained widely debated. To understand this phenomenon we performed a 
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bioinformatics analysis of all the α-helical oligomeric transmembrane proteins with known 
structures to rank them as per their oligomeric stability. We calculated the free energy of oligomeric 
dissociation (ΔG°dissoc(m)) and separately validated the approach through calculation of the interface 
strength from buried surface area and number of salt bridge interactions across the interface (Fig. 1, 
Extended Data Fig. 1 and Supplementary Table S1). For 13 membrane proteins, with predicted high 
oligomeric stability, mass spectra revealed the measured masses are in agreement with that of their 
oligomeric masses, devoid of additional lipids (Fig. 1 and Extended Data Table 1). While membrane 
proteins with high ΔG°dissoc(m) values can still have substantial affinity towards lipids, lipid binding is 
not towards survival of the oligomeric entity [15].  
By contrast, the weakest oligomeric interface was observed for the bacterial leucine transporter 
from Aquifex  aeolicus (LeuT). LeuT is a sodium symporter that transports small aliphatic amino acids 
across the bacterial inner membrane and is the homolog of eukaryotic bioamine transporters [4]. A 
mass spectrum recorded following liberation of LeuT from octylglucoside (OG) micelles reveals its 
dimeric state (Fig. 2). The mass of the dimer was consistently greater than that of twice the 
monomer (126.0 kDa =2×59.3 + 7.4 kDa) over numerous preparations, with different constructs and 
collision energies, indicative of noncovalent binding of small molecules with high affinity and precise 
stoichiometry (Extended Data Fig. 2). Incubating LeuT in neopentyl glycol (NG), a detergent with high 
delipidation properties [16], and reconstituting into OG followed by MS, revealed exclusively 
monomeric LeuT (Extended Data Fig. 3a-c). Addition of E. coli polar lipids to delipidated monomeric 
LeuT, in OG, recovered a significant population of the dimer (Extended Data Fig. 3d). These 
observations imply that the additional mass associated with the dimer is comprised of lipid.   
Conventional lipid identification experiments require extracting lipids from the proteo-micelle 
solution or cellular environment, followed by a chromatographic or MS step [17, 18]. These 
approaches report on the entire set of lipids present but fail to distinguish endogenous lipids binding 
to the membrane protein of interest from those in bulk solution. Identification of bound lipids 
simultaneously with oligomeric state requires a tandem MS (MS/MS) platform, akin to protocols 
developed to sequence peptides for top-down proteomics [19]. MS/MS in its current form cannot be 
applied to membrane proteins directly since the activation energy available in the collision cell is 
used to liberate membrane proteins from detergent micelles [20]. To overcome this problem, we 
developed an instrument platform (Fig. 2a) where high energy applied in the source region removes 
the detergent micelle, prior to entry into the collision cell, enabling isolation of discrete lipid-bound 
complexes in the quadrupole for subsequent MS/MS and lipid identification (Fig. 2a). Using this 
platform, we isolated the 23+ charge state of the dimer that incorporates the 7.4 kDa additional 
mass (Fig 2b). Activation of this species in the collision cell yields monomeric LeuT in apo and lipid-
bound states, with one CDL and up to three phospholipids (PL). Increasing collision energy results in 
monomer retaining one CDL (Extended Data Fig. 4), enabling us to distinguish binding of one CDL 
from the possibility of two PLs. It is important to emphasize that all ions present in the MS/MS 
spectrum originate from dimeric LeuT parent ions with the additional 7.4 kDa, which can now be 
assigned to three PLs and one CDL per subunit (3.7 kDa or 7.4 kDa per dimer).  
Expressing the wild type LeuT in a cardiolipin deficient E. coli strain [21] yielded exclusively 
delipidated monomeric LeuT (Extended Data Fig. 5), confirming that CDL is essential for 
dimerisation. Performing coarse-grained molecular dynamics (MD) simulation of the LeuT dimer in a 
bilayer revealed binding of CDLs and PLs at the dimer interface. Each CDL interacts with both 
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monomeric units, the bi-phosphate head group binding to basic residues on either side of the dimer 
interface (Fig 2c, Extended Fig 5-6, K376, H377 and R506). These results highlight the residues that 
form critical contacts with lipid head-groups to confer the specificity of these interactions. Mutating 
either the dimer interface or these basic residues that bind to CDL abolished dimer formation 
(Extended Data Fig. 5).  We conclude that LeuT has a weak dimer interface, which is stabilised by CDL 
bridging the dimer interface and augmented by six phospholipids.  
Bacterial sugar transporter SemiSWEET from Vibrio splendidus, a functional dimer [6], is another 
protein that has an exceptionally low oligomeric stability, comparable to that of LeuT. The mass 
spectrum of SemiSWEET shows the presence of both monomer and dimer (Extended Data Fig. 7a). 
To investigate if the presence of monomers is a consequence of the removal of lipids during protein 
purification, and whether the monomers are in equilibrium with the dimers, we prepared two mass 
distinct forms of SemiSWEET (+/- deca-His tag, Extended Fig 7). A time course MS experiment, 
subsequent to mixing of these two mass distinct forms in equal ratios, revealed rapid appearance of 
heterodimeric peaks, establishing a solution-phase monomer-dimer equilibrium (Fig. 3a). High 
energy MS/MS of SemiSWEET also identified endogenous bound lipids, a significant proportion of 
which is CDL (Extended Data Fig. 7c). Upon addition of CDL in increasing amounts to this equilibrium 
we observed preferential lipid binding to the dimer and a shift in the equilibrium towards the 
dimeric population (Fig 3b). In contrast addition of phosphatidylglycerol (PG) revealed no such 
preference towards any oligomeric forms (Extended Data Fig. 7d). We conclude that preferential 
lipid binding to the dimer drives the equilibrium towards the functionally active state of the protein.  
Given our emerging hypothesis that lipids are critical for stabilising weak dimer interfaces, we 
searched for proteins with weak interfaces that might require lipids for dimerisation but have 
homologues with higher interface strengths. One such pair of proteins is the NhaA and NapA Na+/H+ 
antiporters from E. coli and T. thermophilus respectively (Fig. 1).  While the oligomeric stability of 
dimeric NhaA is comparable to that of LeuT, dimeric NapA is substantially more stable. The mass 
spectrum of NhaA reveals an ensemble of lipid-bound dimeric species (Fig. 4a) and a complete 
absence of delipidated dimer. Performing MS/MS on the 15+ charge state of the lipid-bound NhaA 
dimer leads to stepwise losses of CDL and yields monomers with one CDL bound as well as an apo 
NhaA dimer that readily dissociates (Extended Data Fig. 8). The appearance of monomeric NhaA is 
coincident with the loss of the second CDL and consistent with CDL stabilizing the dimer structure. 
MD simulations support this observation by revealing that CDL can stabilize the dimeric state by 
binding at the interface (Extended Data Fig. 6). MS analysis of the homologous NapA reveals a 
striking contrast between lipid binding to NhaA and NapA (Fig. 4a). The NapA dimer is completely 
lipid-free, confirming its intrinsic stability in the absence of interfacial lipids. Proteins from 
thermophiles are known to be more stable than their non-thermophilic homologues. In NapA, an 
additional helix not present in NhaA strengthens the interface, essentially removing the requirement 
for lipids in dimer formation. These two proteins, with the same fold, physiological role and purified 
from identical membranes, demonstrate that membrane proteins can either (i) acquire structural 
elements to ensure greater contacts between subunits or (ii) recruit lipids to preserve their 
oligomeric state. 
We anticipate that the ability to form a stable interface or recruit lipids to preserve oligomeric state 
might be a general phenomenon existing in other membrane protein systems, for example G-protein 
coupled receptors (GPCRs) [22]. Calculating the ΔG°dissoc(m) of the two possible interfaces of μ-opioid 
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receptor we observed that TM5/TM6 dimer forms the stronger interface (16.5 kcal mol-1) and TM1-
TM2/H8 is considerably weaker (2.95 kcal mol-1) (Fig. 4b) [23]. However, the tighter interface 
restricts the conformational flexibility required to attain the agonist bound state [24]. The weaker 
interface, , contains a cavity, akin to that found in NhaA, wherein a side chain of a fatty acid has 
been modeled in the crystal structure [24]. The weak dimeric interfaces involving TM1-TM2/H8 can 
also be constructed for many other GPCRs including the β1 adrenergic receptor and κ-opioid 
receptors (0.7 kcal mol-1 and 6.1 kcal mol-1 respectively) (Fig 4b). These very low oligomeric strengths 
are consistent with observations of transient oligomeric states [25] leading us to speculate that 
much of the controversy surrounding the oligomeric state of GPCRs stems from this ability to exist in 
multiple forms, with different interfaces modulated by interfacial lipids, analogous to the monomer - 
dimer equilibrium shown here for SemiSWEET. 
While the intrinsic stability of the oligomers correlates with lipid binding to stabilise interfaces, a key 
question arises with respect to function. For both SemiSWEET and NhaA, existence of a stable 
dimeric state is critical for their mechanistic pathways [26]. Also for NhaA, it has been shown that 
under extreme stress conditions the dimer, observed predominantly with bound lipids, is 
functionally superior to the monomer [27]. By analogy with LeuT, dimerisation of the homologous 
eukaryotic dopamine (DAT) and serotonin transporters (SERT) might also be anticipated in vivo [28, 
29]. Sequence alignment and superposition of the structures of LeuT and SERT reveals that the CDL 
binding residues identified here are conserved in all bioamine transporters (Extended Data Fig. 9). A 
key deviation between the X-ray crystallographic structures of LeuT and SERT arises in the C-terminal 
helix of SERT, which orients away from the subunit interface, preventing dimerization in the crystal 
form [30]. Nevertheless, a functional significance of dimers, or possibly higher oligomers, of SERT is 
well documented [31].  
Overall our data shows how lipid binding at the interface stabilizes weak oligomers and provides 
direct and compelling evidence that altering the lipid composition in solution can propagate changes 
in oligomeric state. In the cellular environment such mechanisms are likely employed to regulate the 
abundance of functional forms of membrane proteins. As new structures of membrane proteins 
continue to emerge, the approach described here will help to resolve conflicts in oligomeric state 
and contribute to our understanding of their functional relevance, important considerations for the 
design of bio therapeutics and for drug targeting. 
Methods  
Methods and associated references are available in the ONLINE METHODS SECTION. 
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Figure 1 | Plot of ΔG°dissoc(m)  for oligomeric α-helical membrane proteins and representative mass 
spectra. Plot of ΔG°dissoc with proteins, grouped by oligomeric state (pentamers+ oligomeric state ≥ 
5). Membrane proteins for which native mass spectra have been acquired are labelled. LeuT, 
SemiSWEET and NhaA (bottom left expansion) have the lowest ΔG°dissoc(m). Two homologous proteins 
with different ΔG°dissoc(m), NapA and NhaA, are also labelled. Mass spectra of trimeric AmtB, 
tetrameric AqpZ and pentameric ELIC (insets clockwise from top left) are shown. A random 
horizontal jitter has been applied to all points to aid visualisation.     
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Figure 2 | Schematic of the high-energy tandem mass spectrometry (HE-MS) platform, mass 
spectra and molecular dynamics (MD) simulations of the lipid-bound LeuT dimer. a, Protein-lipid 
complexes (red/green rods, yellow) are desolvated and liberated from detergent micelles (blue) by a 
high potential difference applied to the cone (box 1). Quadrupole isolation of the protein-lipid 
complex is used to filter out detergent molecules and bulk lipids (box 2). Dissociation of the protein-
lipid complex is then achieved via collision with neutral gas in the collision cell (box 3). Masses of the 
constituent protein and lipids are then measured in the Time-of-Flight mass analyser. b, Mass 
spectrum of LeuT liberated from OG micelles (upper panel) shows monomers (green) and dimers 
(green/grey) with a mass 7.4 kDa greater than the sequence mass. MS/MS of 23+ charge state of 
LeuT (bottom panel) reveals monomers with cardiolipin (CDL, purple head-group) and phospholipid 
(PL, blue head-group) retained. Masses of the lipids bound are marked in black (for PL) and red (for 
CDL) c,  MD simulations of LeuT in an E. coli lipid bilayer reveal  possible binding sites of interfacial 
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phospholipids and CDL (upper panel, viewed from cytoplasmic side of membrane). The CDL 
phosphate groups (orange) interact closely with positively charged residues (K376, H377, R506, blue) 
at the dimer interface. Interactions are shown (yellow dotted lines) with distances measured in Å 
(red). Phosphoethanolamine (PE) and phosphatidylglycerol (PG) also bind at the dimer interface 
(bottom right panel).  
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Figure 3 | Mass spectra recorded for two different forms SemiSWEET that undergo subunit 
exchange and the effect of cardiolipin on the monomer dimer equilibrium. a, Representative mass 
spectrum recorded after incubation in solution of an equimolar ratio of deca-His tagged and 
untagged SemiSWEET (green and black spheres, respectively), liberated from 
tetraethyleneglycolmonooctyl ether (C8E4) micelles. Plot of the percentage abundance of hetero- 
and homo- dimers over time (inset) SemiSWEET heterodimers (red trace, peaks highlighted red in 
mass spectrum) and homodimers (black trace), revealing the solution phase monomer-dimer 
equilibrium (right inset, PDB ID 4QND). b, Mass spectrum of SemiSWEET following incubation with 
cardiolipin (CDL, purple head-groups). Plot of CDL concentration (mg ml-1) versus the percentage of 
monomer or dimer observed in mass spectra at various CDL concentrations is shown (bar chart).  
10 
 
Figure 4 | Comparison of mass spectra of NhaA with NapA and plot of ΔGdissoc values of 
transporters studied here with G-protein coupled receptors. a, Mass spectrum of NhaA (green/grey 
spheres), liberated from C8E4 micelles, reveals binding of cardiolipin (CDL, purple head-groups) and 
phospholipids (PL, blue head-groups) to the intact NhaA dimers. MD simulation of NhaA 
(green/black rods) in an E. coli lipid bilayer (inset) reveals interfacial CDL binding (orange/purple 
spheres). Mass spectrum of dimeric NapA (right), liberated from C8E4 micelles, shows NapA dimers 
(blue/brown spheres) with no lipid binding. b, Oligomeric stability scale (purple) annotated with 
crystal structures of proteins analysed in this study (above) and GPCRs (below) -  ΔG°dissoc values are 
given in brackets. Structures of the protomers of NhaA (green) and NapA (blue) are superimposed. 
This highlights the additional helix in NapA. PDB IDs: 2A65 (LeuT), 4QND (SemiSWEET), 4AU5 (NhaA), 
4BWZ (NapA), 4GPO (β1 adrenergic receptor), 4DKL (µ-opioid receptor), 4DJH (κ-opioid receptor). 
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Online methods 
Molecular cloning and plasmid construction 
LeuT was expressed from a pET-16b vector, containing a thrombin cleavable C-terminal 8 x His tag. 
SemiSWEET was expressed from a pJexpress411 vector, containing a HRV-3C protease cleavable 10 x 
His tag. All point mutations were generated using a Quikchange Lightning Site-Directed mutagenesis 
kit, according to the manufacturer’s protocol. For expression of LeuT in cardiolipin-deficient BKT22 E. 
coli strain, the LeuT gene was amplified by polymerase chain reaction using a Phusion Flex Hot Start 
Polymerase (New England Biolabs) with primers designed for Infusion cloning using the 
manufacturer’s online tool. The PCR product was purified using gel agarose electrophoresis, then 
used in an Infusion cloning reaction (Clontech) with a linearised pBAD vector containing a 10 x His 
tag. The LeuT-eYFP fusion protein was expressed from a pET-15b/pET-23b hybrid vector, containing 
the LeuT gene followed by a TEV protease cleavage site, the eYFP gene (with mutation A206K to 
abolish eYFP dimerisation) and a 6 x His tag. To construct this plasmid, the LeuT gene was amplified 
by PCR as above, and used in an Infusion reaction with a pET-15b/pET-23b hybrid vector 
(Laganowsky, Nature 2014), cut with appropriate restriction enzymes, and a synthetic gene block 
(IDT) containing the TEV site and eYFP gene. All plasmid constructs were confirmed by DNA 
sequencing. 
Membrane protein expression and purification 
The LeuT plasmid was transformed into C43 E. coli (Lucigen), and expressed and purified as reported 
previously [32]. Briefly, multiple colonies were used to inoculate 100 ml of Terrific Broth (TB) and 
grown overnight at 37 °C. 10 ml of overnight culture was used to inoculate each of 6 litres of TB, 
which were allowed to grow at 37 °C until the culture reached an OD600 nm of 0.6. Isopropyl β-D-
thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM, and the cultures grown 
for 16 hours at 20 °C. Cells were harvested by centrifugation at 5,000 g, for 10 min at 4 °C, 
resuspended in lysis buffer solution (300 mM sodium chloride, 20 mM Tris, pH 7.4) supplemented 
with protease inhibitor cocktail (Roche), lysed using a M-110 PS microfluidizer (Microfluidics), and 
the cell debris pelleted by centrifugation at 20,000 g for 25 min at 4 °C. Membranes were pelleted by 
centrifugation of the supernatant at 100,000 g for 2h at 4 °C and subsequently resuspended in ice-
cold Buffer soluition (100 mM sodium chloride, 20 mM Tris, 20 % glycerol, pH 8.0) and homogenised 
using a Potter-Elvehjem Teflon pestle and glass tube. DDM was added to resuspended membranes 
to a final concentration of 2% w/v and the suspension incubated with gentle agitation for 15 hours 
at 4 °C. Insoluble material was pelleted by centrifugation at 20,000g for 30 min and the supernatant 
filtered through 0.22 micron filters. LeuT was purified by immobilised metal ion-affinity 
chromatography using a HisTrap HP 5 ml column (GE healthcare) equilibrated with Buffer A (190 mM 
sodium chloride, 10 mM potassium chloride, 20 mM Tris, 20 mM imidazole, 10 % glycerol, 0.02 % 
DDM, pH 8.0) and eluted with Buffer B (190 mM sodium chloride, 10 mM potassium chloride, 20 
mM Tris, 500 mM imidazole, 10 % glycerol, 0.02 % DDM, pH 8.0). The eluted protein was transferred 
to a dialysis cassette (100 kDa molecular weight cut-off) and dialysed against a dialysis buffer 
solution (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris,10 % glycerol, pH 8.0) + 
0.02% DDM overnight. A 100 kDa MWCO concentrator was used to concentrate the dialysed 
protein. LeuT was then injected onto a Superdex 200 Increase GL 10/300 column (GE Healthcare), 
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equilibrated in a buffer (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris,10 % 
glycerol, pH 8.0)  with 1 % OG. Peak fractions containing OG-solubilised LeuT were concentrated as 
above and used for further study. All protein concentration measurements were carried out using a 
UV/vis spectrophotometer (DS-11 +, DeNovix). 
The Vibrio sp. semiSWEET plasmid was transformed into BL21 DE3 E. coli (Novagen), and expressed 
and purified as reported previously [6]. Briefly, multiple colonies were used to inoculate 100 ml of LB 
and grown overnight at 37 °C. 10 ml of overnight culture was used to inoculate each of 6 liters of LB, 
which were allowed to grow at 37 °C until the culture reached an OD600nm of 0.8. Isopropyl β-D-
thiogalactopyranoside (IPTG) was added to a final concentration of 0.2 mM, and the culture grown 
for 15 hours at 22 °C. Cell harvesting, resuspension, lysis, membrane isolation and detergent 
extraction steps were identical to the LeuT purification. semiSWEET was first purified by IMAC using 
a HisTrap HP 5 ml column (GE healthcare) equilibrated with Buffer A (150 mM sodium chloride, 20 
mM Tris, 20 mM imidazole, 10 % glycerol, 1 mM DTT, 0.02 % DDM, pH 8.0) and eluted with Buffer B 
(150 mM sodium chloride, 20 mM Tris, 500 mM imidazole, 10 % glycerol, 1 mM DTT, 0.02 % DDM, 
pH 8.0). The eluted protein and HRV 3C protease (Novagen) were transferred to a dialysis cassette 
(30 kDa molecular weight cut-off), and dialysed against buffer (150 mM sodium chloride, 20 mM 
Tris,10 % glycerol, 1 mM DTT, pH 8.0) with 0.02% DDM overnight. For preparation of 10 x His 
semiSWEET, no HRV 3C protease was added to the dialysis cassette. A 50 kDa MWCO concentrator 
was used to concentrate the dialysed protein. semiSWEET was then injected onto a Superdex 200 
Increase GL 10/300 column (GE Healthcare), equilibrated in a buffer solution (150 mM sodium 
chloride, 20 mM Tris, 10 % glycerol, 1 mM DTT, 0.02 % DDM, pH 8.0)  + 0.5 % C8E4. Peak fractions 
containing C8E4-solubilised semiSWEET were concentrated as above and used for further study.  
NapA, NhaA, AqpZ, AmtB and ELIC were expressed as described before [13, 33-35]. 
Non-denaturing mass spectrometry 
Samples were prepared for non-denaturing mass spectrometry by buffer-exchange into MS buffer 
(200 mM ammonium acetate, 2 x CMC of detergent of interest, pH 7.4) using a centrifugal buffer 
exchange device (Micro Bio-Spin, Biorad). For semiSWEET experiments, 1 mM DTT was also added to 
the MS buffer. 
Mass spectrometry measurements were performed on a Synapt G1(Waters) with a Z-spray source, 
using nanoelectrospray capillaries prepared in-house [36]. The source pressure was set to 4-7 mBar, 
with a capillary voltage of 1.4-1.7 kV, capillary nanoflow of 0.05 - 0.2 mBar and argon as collision 
(trap) gas at flow rate of 1.5-8.0 ml min-1. Other parameters, including the sample and extraction 
cone and trap bias voltages, collision voltages and quadrupole profile were optimised for maximal 
ion intensity and minimal dissociation of the target membrane protein complex. Data was processed 
using MassLynx software. 
 
High energy non-denaturing mass spectrometry 
To allow the use of higher voltages on the extraction cone in the source region of the Synapt G2, the 
configuration file for the extraction cone was modified to increase the maximum voltage setting 
from 10V to 200V.  However, altering this setting alone would restrict the maximum sample cone 
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voltage that could be accessed due to the limits imposed by the power supplies.  To overcome this 
limitation, the capability to drive the sample cone voltage from an external supply was 
implemented.  This took the form of a patch cable introduced between the instrument lens control 
PCB and the source ion block.  The ion block contains both heater elements and a thermocouple in 
addition to supporting the extraction cone and these were decoupled with the patch cable to 
prevent possible electrical breakdown with use of higher cone voltages.  The extraction cone was 
patched directly through from the lens PCB whilst the sample cone voltage was decoupled and a 
new wire connection made to an external power supply. 
Delipidation 
Purified, OG-solubilised LeuT was incubated in 2% NG overnight at 4 °C. Subsequently, the sample 
passes through a Superdex 200 Increase GL 10/300 column (GE Healthcare) equilibrated in 200mM 
ammonium acetate with twice CMC amount of NG, to remove the excess OG and NG. This sample 
was subjected to MS analysis. The delipidated LeuT in NG was re-exchanged back in OG using the 
above protocol with, the 200mM ammonium acetate containing 1% OG. E. coli polar lipid stocks 
were made from powder (Avanti Polar Lipids Inc., Alabama USA) at a concentration of 10mg/ml 
using previously published methods [13] and subsequently diluted 50 times in 200mM ammonium 
acetate solution containing 1%OG. A dilyso-CDL stock of (10 mg/ml in 200 mM ammonium acetate) 
was prepared as described previously [35]; aliquots of this stock were diluted 50 times in 200mM 
ammonium acetate solution containing 1%OG for each MS experiment. 
Preparation and titration of phospholipids 
Purified semiSWEET-His10 in MS buffer was diluted to an oligomer concentration of 20 µM. A 
cardiolipin stock (10 mg/ml in 200 mM ammonium acetate) was prepared as described previously 
[35]; aliquots of this stock were diluted in MS buffer to a CDL concentration 2x that required for each 
MS experiment. Diluted semiSWEET and cardiolipin solutions were then mixed 1:1 and incubated on 
ice for 5 mins (for the measurement without CDL, semiSWEET was mixed with MS buffer). 2 µL of 
this mixture was then used for each of three MS measurements at the 4 lipid concentrations. 
 
Data was acquired for 100 scans, which were summed in MassLynx software and processed using 
UniDec deconvolution software [37]. Relative monomer and dimer abundances were calculated by 
taking the sum of the respective deconvoluted intensities in all lipidation (and non-lipidated) states, 
normalised to the total intensity of all semiSWEET species, and averaged over the 3 repeats (error 
bars are +/- 1 standard deviation). A plot of relative monomer and dimer abundances against 
cardiolipin concentration was generated using SigmaPlot. 
 
MS measurements were performed on a Synapt G1 as described above.  The source pressure was 
set to 4.2 mBar, capillary nanoflow 0.1 mBar, trap collision voltage 50 V, transfer collision voltage 10 
V and collision gas flow rate 1.8 ml min-1. 
 
Subunit exchange  
Purified, C8E4-solubilised semiSWEET and semiSWEET-His10 were separately buffer-exchanged into 
MS buffer as described above, then concentrated to 40 µM using a 30 kDa MWCO concentrator. 3 µL 
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of semiSWEET and semiSWEET-His10 were then mixed briefly on ice. 3 µL of this equimolar mixture 
was immediately transferred to a nanoelectrospray capillary for MS data acquisition. MS data was 
acquired continuously for 10 minutes. 
Data was processed using Xcalibur software (Thermo Scientific) as follows: spectra were extracted 
from summation of the chromatogram in 30 second scan windows centred on each minute e.g. 0.75 
- 1.25 min for the 1 min time point. Relative abundances of the semiSWEET and semiSWEET-His10 
homodimers and the semiSWEET.semiSWEET-His10 heterodimer were calculated for each time point 
using UniDec. A plot of relative homodimer abundance and heterodimer abundance against time 
was generated using SigmaPlot. 
MS measurements were performed on a modified Q-Exactive orbitrap mass spectrometer (Thermo 
Fisher, Bremen Germany) [38] modified and optimised for non-denaturing MS of membrane protein 
complexes. Spectra were acquired in “Native Mode” with maximum RF applied to all ion optics, -
3.2 kV to the central electrode of the Orbitrap and with ion trapping in the HCD cell. Ions were 
generated in positive ion mode from a static nanospray source using gold-coated capillaries 
prepared in-house. Transient times were 64 ms and AGC target was 1×106. Spectra were acquired 
with 1 microscan, a noise level parameter set to 3 and HCD cell voltage of 75 V; no in-source 
activation was applied. The collision gas was Argon and pressure in the HCD cell was maintained at 
approximately 1×10-9 mbar. 
Molecular dynamics simulations 
All MD simulations were performed using GROMACS v5.1.2 [39]. The MemProtMD pipeline [40] was 
used with the Martini 2.2 force field [41] to run five repeats of a 1 μs Coarse Grained (CG) MD 
simulation of the dimeric protein complexes. Last 800ns of each of these simulation trajectories 
were considered for further analysis. The proteins were centered within the simulation system to 
permit the assembly and equilibration of 10 % cardiolipin with either a 20% 1-palmitoly, 2-oleoyl, 
phosphatidylglycerol (POPG): 70% 1-palmitoyl, 2-oleoyl, phosphatidylethanolamine (POPE) or 90 % 
1-palmitoyl, 2-oleoyl, phosphatidylcholine (POPC) bilayers.  Systems were neutralised with a 150 
mM concentration of NaCl. All simulations were performed at 323K, with protein, lipids and solvent 
separately coupled to an external bath using the velocity-rescale thermostat [42]. Pressure was 
maintained at 1 bar with a semi-isotropic compressibility of 5 x 10-6 using the Berendsen barostat 
[43]. All bonds were constrained with the P-LINCS algorithm [44]. Electrostatics was measured using 
the Reaction Field method [45], while a Verlet cut-off scheme to permit GPU calculation of non-
bonded contacts was used for Lennard-Jones parameters [46]. Simulations were performed with an 
integration time-step of 20 fs. Atomistic  snapshots at the end-point of the CGMD simulations were 
created by using CG2AT [47] in combination with Alchembed [48]. The lipid densities and contacts 
with the protein during the MD simulations were calculated using MDAnalysis [49], and locally 
written code. All images and animations were generated using Pymol [50]. 
 
Estimation of Oligomeric stability and box plot analysis: Calculation of ΔG°dissoc(m) , buried interface, 
salt bridge and ΔG°stab calculation  
A database of integral oligomeric membrane proteins, for which crystal structures have been 
obtained, was created from the MPStruc database (http://blanco.biomol.uci.edu/mpstruc/). 
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Subsequently, ΔG°dissoc , buried surface area and the number of salt bridge of interactions were 
calculated using PDBePISA webserver [51].  
Further, as we are effectively analysing the equilibrium of the form 𝑛 𝑀1  ⇌  𝑀𝑛  , the obtained 
ΔG°dissoc values cannot be compared across different oligomeric states.  
To address this concern, we adjusted the equilibria to the form  𝑀1  ⇌
1
𝑛
 𝑀𝑛, which can be physically 
interpreted as a free energy change per monomer on joining the complex. This adjustment 
approximately corrects, for example, for unbalanced translational free energy (PNAS, 2010, 107: 
2007). 
So the new ΔG°dissoc(m) is calculated as: Δ 𝐺𝑑𝑖𝑠𝑠𝑜𝑐(𝑚) =  
1
𝑛
 Δ 𝐺𝑑𝑖𝑠𝑠𝑜𝑐  Where n = Oligomeric state, as 
described in and ΔG°dissoc is the value obtained from PISA.  
ΔG°dissoc(m) were visualised using a scatter generated using the Matplotlib library for the Python 
programming language. Superimposed on this is a circle for each protein, whose vertical position 
was determined by its ΔG°dissoc(m) value and horizontal position by its oligomeric state. To reduce 
overlap of points, an arbitrary horizontal jitter (sampled randomly from a uniform distribution) was 
applied to each point and the Y-axis was plotted in log scale. Same protocol was followed to plot 
total buried surface area and the number of salt bridges against the oligomeric state. 
We further validated this approach by calculating interface strength through buried surface area and 
salt bridge interactions, both of which were proposed to be reasonable proxies of interface strength 
(J. Mol. Biol, 1976, 105, 1; Nature, 2008, 453: 1262; J R Soc. Interface, 2012, 10: 20120835; Protein 
Science, 2013, 22: 510).  
In PISA, the effect of buried surface area and number of slat bridges are cumulated by multiplying 
the buried surface area by atomic solvation parameters (ASP) and number of salt bridge by Esb 
Δ 𝐺𝑠𝑡𝑎𝑏 = ∑  (𝜎 × 𝜔) + ∑  (𝑁𝑠𝑏  ×  𝐸𝑠𝑏)  (i) 
 
Where σ = buried surface area, ω= Atomic solvation parameter (ASP), Nsb = total number of salt 
bridges, Esb = energy contribution of each of the salt bridges and ΔG°stab = stabilization energy. The 
more positive the value of ΔG°stab the more stable the oligomeric species 
In PISA, the Esb value is assigned as 0.15 kcal/mol based on a bulk water dielectric constant of 80. As 
suggested by the reviewer, for the current data set of integral membrane proteins, such interactions 
in the bilayer would scale up due to the very low dielectric of the medium. We have thus now 
modified this value by a factor of 40 (0.15kcal/mol × 40 = 6 kcal/mol) to account for the lower 
dielectric constant in the bilayer (ε = 2) (PNAS USA, 1984, 84: 5412). Likewise, the buried surface 
area contribution was converted to an energy contribution based on an ASP value of 7 cal/Å (PNAS 
USA, 2011, 31: E359).  
Hence the new ΔG°stab revised for the bilayer environment is calculated as  
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                                      Δ 𝐺𝑠𝑡𝑎𝑏 =
𝜎 ×7
1000
+ 𝑁𝑠𝑏  × 6  (ii) 
 
For reasons mentioned above the obtained was divided by the oligomeric state and plotted against 
the oligomeric state using the same protocol.  
LeuT/SERT Structure alignment  
The structure of LeuT (PDB ID 2A65) and SERT (5I6Z) were superimposed using PyMOL and the 
sequence alignment of LeuT with the BATs were done using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The individual sequences were obtained from Uniprot. 
 
1. Arkhipov, A., et al., Architecture and membrane interactions of the EGF receptor. Cell, 2013. 
152(3): p. 557-69. 
2. Wu, H., et al., Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an 
allosteric modulator. Science, 2014. 344(6179): p. 58-64. 
3. Duarte, J.M., et al., An analysis of oligomerization interfaces in transmembrane proteins. 
BMC Struct Biol, 2013. 13: p. 21. 
4. Piscitelli, C.L., H. Krishnamurthy, and E. Gouaux, Neurotransmitter/sodium symporter 
orthologue LeuT has a single high-affinity substrate site. Nature, 2010. 468(7327): p. 1129-
32. 
5. Penmatsa, A. and E. Gouaux, How LeuT shapes our understanding of the mechanisms of 
sodium-coupled neurotransmitter transporters. J Physiol, 2014. 592(5): p. 863-9. 
6. Xu, Y., et al., Structures of bacterial homologues of SWEET transporters in two distinct 
conformations. Nature, 2014. 515(7527): p. 448-52. 
7. Yeagle, P.L., Non-covalent binding of membrane lipids to membrane proteins. Biochim 
Biophys Acta, 2014. 1838(6): p. 1548-59. 
8. Hansen, S.B., X. Tao, and R. MacKinnon, Structural basis of PIP2 activation of the classical 
inward rectifier K+ channel Kir2.2. Nature, 2011. 477(7365): p. 495-8. 
9. Gao, Y., et al., TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action. 
Nature, 2016. 
10. Whitelegge, J.P., Integral membrane proteins and bilayer proteomics. Anal Chem, 2013. 
85(5): p. 2558-68. 
11. Savas, J.N., et al., Mass spectrometry accelerates membrane protein analysis. Trends 
Biochem Sci, 2011. 36(7): p. 388-96. 
12. Konijnenberg, A., et al., Extending native mass spectrometry approaches to integral 
membrane proteins. Biol Chem, 2015. 396(9-10): p. 991-1002. 
13. Laganowsky, A., et al., Membrane proteins bind lipids selectively to modulate their structure 
and function. Nature, 2014. 510(7503): p. 172-5. 
14. Landreh, M., et al., A sliding selectivity scale for lipid binding to membrane proteins. Curr 
Opin Struct Biol, 2016. 39: p. 54-60. 
15. Pliotas, C., et al., The role of lipids in mechanosensation. Nat Struct Mol Biol, 2015. 22(12): p. 
991-8. 
16. Ilgu, H., et al., Variation of the detergent-binding capacity and phospholipid content of 
membrane proteins when purified in different detergents. Biophys J, 2014. 106(8): p. 1660-
70. 
17. Brugger, B., Lipidomics: analysis of the lipid composition of cells and subcellular organelles by 
electrospray ionization mass spectrometry. Annu Rev Biochem, 2014. 83: p. 79-98. 
19 
18. Taki, T., TLC-Blot (Far-Eastern Blot) and Its Application to Functional Lipidomics. Methods 
Mol Biol, 2015. 1314: p. 219-41. 
19. Cox, J. and M. Mann, Quantitative, high-resolution proteomics for data-driven systems 
biology. Annu Rev Biochem, 2011. 80: p. 273-99. 
20. Barrera, N.P., et al., Micelles protect membrane complexes from solution to vacuum. Science, 
2008. 321(5886): p. 243-6. 
21. Tan, B.K., et al., Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and 
phosphatidylglycerol as substrates. Proc Natl Acad Sci U S A, 2012. 109(41): p. 16504-9. 
22. Audet, M. and M. Bouvier, Restructuring G-protein- coupled receptor activation. Cell, 2012. 
151(1): p. 14-23. 
23. Huang, W., et al., Structural insights into micro-opioid receptor activation. Nature, 2015. 
524(7565): p. 315-21. 
24. Sounier, R., et al., Propagation of conformational changes during mu-opioid receptor 
activation. Nature, 2015. 524(7565): p. 375-8. 
25. Dorsch, S., et al., Analysis of receptor oligomerization by FRAP microscopy. Nat Methods, 
2009. 6(3): p. 225-30. 
26. Drew, D. and O. Boudker, Shared Molecular Mechanisms of Membrane Transporters. Annu 
Rev Biochem, 2016. 85: p. 543-72. 
27. Herz, K., et al., Beta-sheet-dependent dimerization is essential for the stability of NhaA 
Na+/H+ antiporter. J Biol Chem, 2009. 284(10): p. 6337-47. 
28. Anderluh, A., et al., Single molecule analysis reveals coexistence of stable serotonin 
transporter monomers and oligomers in the live cell plasma membrane. J Biol Chem, 2014. 
289(7): p. 4387-94. 
29. Zhen, J., et al., Dopamine transporter oligomerization: impact of combining protomers with 
differential cocaine analog binding affinities. J Neurochem, 2015. 133(2): p. 167-73. 
30. Coleman, J.A., E.M. Green, and E. Gouaux, X-ray structures and mechanism of the human 
serotonin transporter. Nature, 2016. 532(7599): p. 334-9. 
31. Kilic, F. and G. Rudnick, Oligomerization of serotonin transporter and its functional 
consequences. Proc Natl Acad Sci U S A, 2000. 97(7): p. 3106-11. 
32. Yamashita, A., et al., Crystal structure of a bacterial homologue of Na+/Cl--dependent 
neurotransmitter transporters. Nature, 2005. 437(7056): p. 215-23. 
33. Coincon, M., et al., Crystal structures reveal the molecular basis of ion translocation in 
sodium/proton antiporters. Nat Struct Mol Biol, 2016. 23(3): p. 248-55. 
34. Lee, C., et al., Crystal structure of the sodium-proton antiporter NhaA dimer and new 
mechanistic insights. J Gen Physiol, 2014. 144(6): p. 529-44. 
35. Laganowsky, A., et al., Mass spectrometry of intact membrane protein complexes. Nat 
Protoc, 2013. 8(4): p. 639-51. 
36. Hernandez, H. and C.V. Robinson, Determining the stoichiometry and interactions of 
macromolecular assemblies from mass spectrometry. Nat Protoc, 2007. 2(3): p. 715-26. 
37. Marty, M.T., et al., Bayesian deconvolution of mass and ion mobility spectra: from binary 
interactions to polydisperse ensembles. Anal Chem, 2015. 87(8): p. 4370-6. 
38. Gault, J., et al., High-resolution mass spectrometry of small molecules bound to membrane 
proteins. Nat Methods, 2016. 
39. Abraham, M.J., et al., GROMACS: High performance molecular simulations through multi-
level parallelism from laptops to supercomputers. SoftwareX, 2015. 1–2: p. 19-25. 
40. Stansfeld, P.J., et al., MemProtMD: Automated Insertion of Membrane Protein Structures 
into Explicit Lipid Membranes. Structure, 2015. 23(7): p. 1350-61. 
41. de Jong, D.H., et al., Improved Parameters for the Martini Coarse-Grained Protein Force 
Field. Journal of Chemical Theory and Computation, 2013. 9(1): p. 687-697. 
42. Bussi, G., D. Donadio, and M. Parrinello, Canonical sampling through velocity rescaling. J 
Chem Phys, 2007. 126(1): p. 014101. 
20 
43. Berendsen, H.J.C., et al., Molecular-Dynamics with Coupling to an External Bath. Journal of 
Chemical Physics, 1984. 81(8): p. 3684-3690. 
44. Hess, B., P-LINCS: A parallel linear constraint solver for molecular simulation. Journal of 
Chemical Theory and Computation, 2008. 4(1): p. 116-122. 
45. Tironi, I.G., et al., A Generalized Reaction Field Method for Molecular-Dynamics Simulations. 
Journal of Chemical Physics, 1995. 102(13): p. 5451-5459. 
46. Pall, S. and B. Hess, A flexible algorithm for calculating pair interactions on SIMD 
architectures. Computer Physics Communications, 2013. 184(12): p. 2641-2650. 
47. Stansfeld, P.J. and M.S. Sansom, Molecular simulation approaches to membrane proteins. 
Structure, 2011. 19(11): p. 1562-72. 
48. Jefferys, E., et al., Alchembed: A Computational Method for Incorporating Multiple Proteins 
into Complex Lipid Geometries. J Chem Theory Comput, 2015. 11(6): p. 2743-2754. 
49. Michaud-Agrawal, N., et al., Software News and Updates MDAnalysis: A Toolkit for the 
Analysis of Molecular Dynamics Simulations. Journal of Computational Chemistry, 2011. 
32(10): p. 2319-2327. 
50. DeLano, W.L., The PyMOL Molecular Graphics System. 2002. http://www.pymol.org. 
51. Krissinel, E. and K. Henrick, Inference of macromolecular assemblies from crystalline state. J 
Mol Biol, 2007. 372(3): p. 774-97. 
52. Sturt, H.F., et al., Intact polar membrane lipids in prokaryotes and sediments deciphered by 
high-performance liquid chromatography/electrospray ionization multistage mass 
spectrometry--new biomarkers for biogeochemistry and microbial ecology. Rapid Commun 
Mass Spectrom, 2004. 18(6): p. 617-28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Extended Data Table 1: Summary of the mass spectral analysis and ΔGdissociation membrane proteins 
forming strong oligomers 
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Extended Data Figure 1 | Oligomeric interface stability of membrane proteins. a, Buried surface 
area, b, the number of salt bridges and c, ΔG°stab of oligomeric membrane proteins as a function of 
oligomeric state. Data points of different oligomeric states are independently coloured. The data 
points for LeuT, NhaA and SemiSWEET are coloured red. The analysis shows buried surface are, 
bumber of salt bridges or combine (ΔG°stab), irrespective of the matrix used that LeuT, NhaA and 
SemiSWEET rank amongst the weakest oligomeric membrane proteins. These three proteins contain 
no salt bridges. The 13 other proteins for which lipid-free assemblies have been observed by mass 
spectrometry are also labelled. d, shows the for all the 16 proteins used the PISA predicted 
oligomeric state matched with that of the experimentally determined oligomeric state. 
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Extended Data Figure 2 | Mass spectra of LeuT recorded with increasing collision voltages and of a 
LeuT fusion protein construct. a, Mass spectra of LeuT, liberated from OG micelles, (green/grey 
spheres, most abundant charge state highlighted in pale blue), show that the 7.4 kDa lipid adduct 
(blue/purple head groups), is retained throughout the trap collision energy range (white, blue arrow) 
of the mass spectrometer. b, Mass spectra of LeuT expressed as a fusion protein with eYFP (LeuT-
eYFP yellow circles), liberated from OG micelles, show that the dimer is similarly associated with a 
7.4 kDa adduct.    
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Extended Figure 3 | Mass spectra of LeuT following incubation with delipidating 
detergents and E. coli polar lipids. a, Mass spectrum of LeuT liberated from OG micelles 
(green head groups) shows low-abundance, delipidated monomers (green spheres, 59.3 
kDa) and high-abundance, lipid-bound dimers (green/black spheres, 126.0 kDa). b, Mass 
spectrum of LeuT after incubation with neopentyl glycol (NG, orange head-groups) shows 
only delipidated monomers. c, Mass spectrum of LeuT after incubation with NG, then OG 
shows only delipidated monomers. d, Mass spectrum recorded after incubation of 
delipidated LeuT monomers with OG and E. coli polar lipids (blue/purple head-groups) 
shows delipidated monomers and lipid-bound dimers. e, Mass spectrum recorded after 
adding dilysocardiolipin (blue head-groups) to delipidated monomeric LeuT (c) shows no 
dimerisation in the presence of this lipid.  
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Extended Figure 4: High energy MS/MS experiment of the 23+ charge state of dimeric LeuT, with 
the 7.4 kDa adduct, as a function of collision voltage. Three satellite peaks represent the lipid 
bound states arising through the dissociation of the monomer. The naked monomer is highlighted in 
blue, while the three satellite peaks assigned to one phospholipid (PL), one CDL and two PL bound 
species (red, green and yellow respectively). Under higher energy, only the CDL bound species 
remains, discounting the mathematical possibility of two PL bound species.   Inset shows the isolated 
23+charge state of the lipid bound dimer. Presence of bound CDL at higher energy, over PL indicates 
a higher binding energy of CDL over the latter, plausibly owing to greater ionic and hydrophobic 
interactions. 
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Extended Data Figure 5 | Site directed mutagenesis of selected residues at the LeuT dimer 
interface, resulting mass spectra and MD simulations. a, The LeuT dimer interface, showing π-
stacking interactions (yellow dotted lines, distances labelled in red) between aromatic residues 
(purple). When residues F488 and Y489 (orange arrows) are mutated to alanine the π-stacking 
interactions are abolished and LeuT cannot dimerize.   b, Mass spectrum of LeuT F488AY489A, 
liberated from OG micelles, reveals monomeric LeuT (green spheres). c, Mass spectrum of LeuT 
expressed in a CDL-deficient E. coli strain (BKT22), liberated from OG micelles, reveals monomeric 
LeuT, implying that CDL is required for LeuT dimerisation. d, Mass spectrum of LeuT K376AH377A, 
liberated from OG micelles, reveals monomeric LeuT. Insert: MD simulations of LeuT reveal CDL 
phosphate groups (orange sticks) interacting closely with positively charged residues (K376, H377, 
R506, blue sticks) at the dimer interface. Interactions are shown as dotted lines with distances 
measured in Å.  
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Extended Data Figure 6 | Particle densities from five repeats of 1 µs Coarse-grained MD simulations 
for CDL around (a) LeuT. The surface densities represent the most occupied positions from the 
simulations of the phosphate (orange), glycerol (red) and alkyl tails (purple) particles of CDL. As the 
figures show the proposed binding sites at the interface are the only places where CDL shows 
considerable population density. Comparative of particle densities of (b) CDL, (c) PG and (d)PE at the 
LeuT dimeric interface, summed over the simulations show no/minimal densities of PG and PE at the 
CDL binding site. (a)-(d) together shows that the proposed binding sites of CDL at the interface are 
sites of specific bindings. e, Dimeric structure of LeuT with modelled APT (aminopentanetetrol, 
aminophospholipids) classes of lipid present in the A. Aeolicus [52]. The lipid was drawn in 
ChemDraw and subsequently modelled by superimposing it on the CDL to the CDL bound dimeric 
structure. The favorable van der Waals’ distances show that it is capable of bridging the dimeric 
entity, through the same sets of residues that were found to be critical towards CDL binding, in an 
endogenous environment lacking CDLs. f, Particle densities from five repeats of 1 µs Coarse-grained 
MD simulations for CDL around NhaA binding of two CDLs at the dimer interface. g,  
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Extended Data Figure 7 | Mass spectra of His-tagged and unmodified SemiSWEET and 
identification of endogenous and exogenous lipid binding a, Mass spectrum of unmodified 
SemiSWEET, liberated from tetraethyleneglycolmonooctyl ether (C8E4) micelles, reveals SemiSWEET 
monomers and dimers (black spheres). b, Mass spectrum of deca-His tagged SemiSWEET, liberated 
from C8E4 micelles, reveals SemiSWEET monomers and dimers (green spheres).  c, High energy 
MS/MS of unmodified SemiSWEET, liberated from dodecylmaltoside (DDM) micelles, allows isolation 
of the 6+ charge state (black spheres) of the SemiSWEET monomer (black spheres) bound to 
endogenous lipids. Fragmentation of the lipid-bound species leads to loss of either cardiolipin (1470 
± 26 Da, purple head-groups), 1 or 2 neutral phospholipids (each 756 ± 22 Da, blue head-groups), or 
a positively charged phospholipid. Trap collision voltages shown in white inside blue arrow. d, Mass 
spectrum of deca-His SemiSWEET, liberated from C8E4 micelles and incubated with 
phosphatidylglycerol (PG, blue head-groups). PG binds to both monomers and dimers (dotted boxes 
highlight lipid-bound peaks) without substantial preference. 
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Extended Data Figure 8 | Mass spectrum and high-energy MS/MS of NhaA at a range of collision 
voltages a, Mass spectrum of NhaA, liberated from C8E4 micelles, reveals NhaA monomers (green 
spheres) bound to CDL (purple head-groups) and an ensemble of NhaA dimer species in different 
lipidation states (highlighted in green). b, MS/MS of the 15+ charge state (green) of the NhaA dimer 
(green/black spheres) bound to 2 CDL liberated from C8E4 micelles. Increasing collision voltage 
applied to the 2 x CDL-bound species leads to: loss of 1 CDL to form NhaA dimers bound to 1 CDL (40 
V); loss of 2 CDL to form delipidated NhaA dimers, with concomitant generation of NhaA monomers 
(70 V) and further dissociation of NhaA dimers into monomers (120 V). Trap collision voltages (white 
inside blue arrow). 
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Extended Data Figure 9 | Sequence and structure alignment of LeuT with other eukaryotic 
bioamine transporters (BATs). a, The basic residues of LeuT that are involved in lipid binding (red 
box) are conserved across the BATs. b, Two views of the superimposed structures of LeuT (PDB ID 
2A65, black) and SERT (PDB ID 5I6Z, light blue) show the differences in the dimer interface. Dimer 
interface helices are highlighted with arrows and coloured (LeuT green, SERT red); basic residues 
responsible for lipid binding in LeuT (yellow mesh). One of the interface helices in SERT swings away 
from the interface, negating the possibility of lipid-induced oligomerisation analogous to that 
proposed for LeuT.  
 
 
 
 
 
